Neogenomic

NeoGenomics is a leading provider of cancer-focused genetic testing and diagnostic services, supporting oncologists, pathologists, pharmaceutical companies, and hospitals across the United States and internationally. The company generates revenue primarily by offering a comprehensive menu of molecular, cytogenetic, and flow cytometry tests that help guide cancer diagnosis, prognosis, and therapy selection, as well as by providing clinical trial support to pharmaceutical partners. Founded in 2001 and headquartered in Fort Myers, Florida, NeoGenomics has expanded through acquisitions and investments in advanced laboratory technologies to remain at the forefront of precision oncology. Candidates should note NeoGenomics’ emphasis on innovation, quality, and collaboration within a rapidly evolving healthcare landscape. The company’s mission centers on improving patient care through actionable insights derived from cutting-edge genomic science.

Recent Posts by Neogenomic

1-20 of 300